Litcius/Paper detail

A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus

Minato Hirano, Yasuteru Sakurai, Shuzo Urata, Yohei Kurosaki, Jiro Yasuda, Kentaro Yoshii

2022Antiviral Research11 citationsDOIOpen Access PDF

Topics & Concepts

VirologyViral replicationVirusBiologyNucleoproteinLuciferaseReverse geneticsCell cultureTransfectionBiochemistryGeneMutantGeneticsViral Infections and VectorsPlant Virus Research StudiesViral Infections and Outbreaks Research
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus | Litcius